Skip to content

Acceptance of Telemedicine in Dermatology Patients, Physicians and Medical Staff

Acceptance of Telemedicine in Dermatology Patients, Physicians and Medical Staff

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04495036
Enrollment
683
Registered
2020-07-31
Start date
2019-07-01
Completion date
2020-01-31
Last updated
2020-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatologic Disease

Keywords

Teledermatology, Telemedicine

Brief summary

This study is to investigate the current use and intention to use of teledermatology in Swiss dermatology patients, dermatologists, other physicians and medical staff.

Detailed description

Telemedicine, the use of telecommunication and information technology to provide clinical health care from a distance, has become an increasing role in basic medical care internationally. Telemedicine is particularly suitable for skin diseases. In order to improve the use of evidence-based telemedicine, the Swiss patients' preferences regarding teledermatology versus face-to-face consultations and the patients' and physicians' determinants of acceptance for teledermatology are investigated in this study. Dermatology patients are asked to complete a newly-created 21-items-survey; Swiss dermatologists, other physicians and medical staff on telemedicine will complete a similar newly-created, 23-items-questionnaire. A descriptive statistical analysis (e.g. gender, age, place of residence (city or country), waiting time) will be performed.

Interventions

OTHERdata collection (21-items-patient descriptive survey)

Dermatology patients are asked to complete a 21-items-survey while waiting for the doctor's consultation. Following variables will be addressed: * Demographic data of telemedicine users and non-users * Subjective disease perception of the dermatology patients * Use of internet, telemedicine and telemedicine insurance model * Patients´ willingness for additional features of telemedicine * Advantages and disadvantages telemedicine and face-to-face consultation * Suitable fields of dermatology for telemedicine from the patient's perspective * Recommended structure of telemedical services by users and non-users

OTHERdata collection (23-items-physician descriptive survey)

To obtain the view of Swiss dermatologists, other physicians and medical staff on telemedicine a 23-items-survey will be completed. Following variables will be addressed: * Objective disease perception of the treating dermatologist (regarding the urgency of the patient's medical examination, the functional impairment and cosmetic burden due to patient's disease, the impairment of life quality due to patient's disease and the estimation of the course of the patient's disease) * Suitable fields of dermatology for telemedicine from the physician's and medical staff's perspective

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* patients treated in the Department of Dermatology of the Cantonal Hospital Aarau and the University Hospitals Basel and Zürich * dermatologists, other physicians and medical staff of the Department of Dermatology of the Cantonal Hospital Aarau and the University Hospitals Basel and Zürich

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
descriptive analysis of the impact of medical education for the acceptance of telemedicine among dermatologists vs. other physicians vs. medical staff vs. patientsat baselineComparison of the impact of medical education for the acceptance of telemedicine among dermatologists vs. other physicians vs. medical staff vs. patients
descriptive analysis: deviation in influencing factors for the acceptance of teledermatologyat baselineAssessment of the deviation in influencing factors for the acceptance of teledermatology (subjective disease perception versus objective assessment by physicians)

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026